30.10.2014 16:47:40 CET
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE USA, AUSTRALIA, CANADA, HONG KONG, JAPAN OR SOUTH AFRICA OR ANY OTHER JURSIDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION IS UNLAWFUL.
Nexstim Plc's Prospectus supplemented -
indicative price range lowered, number of offer shares increased and subscription period extended
Helsinki, 30 October 2014 at 5.45
The board of directors of Nexstim Plc ("Nexstim" or the "Company") has, on 30 October 2014, resolved to amend the terms and conditions of its initial public offering ("Offering") published on 13 October 2014 as set out below:
The Company has drawn up a supplement to the prospectus dated 10 October 2014 regarding the amendments to the terms and conditions of the Offering. The Finnish Financial Supervisory Authority has, on 29 October 2014, approved the supplement which is attached in full to this company release.
Following this publication of the supplement to the prospectus, investors subscribing for offer shares in the Finnish retail offering must pay, when placing the subscription, an initial subscription price per offer share of EUR 6.40, i.e., the high point of the amended indicative price range.
Nexstim's Certified Adviser under the First North rules is UB Capital Ltd.
Additional information on the Offering is available in the prospectus published by Nexstim on 13 October 2014, available at www.nexstim.com/IPO.
|Subscription period ends:||3 November 2014|
|Allocation and the final offer price announced:||4 November 2014|
|Due date of payment for offer shares in the institutional offering and Swedish retail offering:|| |
7 November 2014
|Offer shares registered with the Finnish Trade Register (estimated):||13 November 2014|
|Offer shares delivered, trading in shares commences on Nasdaq First North Finland and Nasdaq First North Sweden (estimated):|| |
14 November 2014
Investors who have subscribed for offer shares before the publication of the supplement to the prospectus may choose to cancel their subscriptions. The cancellation right must be exercised within a cancellation period of two Finnish banking days from the publication of this supplement to the Prospectus, i.e., no later than on 3 November 2014 at 18:00 Finnish time (17:00 Swedish time).
Cancellations must be filed with the office with which the subscription was placed. However, subscriptions placed on the website of UB Securities cannot be cancelled on the website but should be cancelled by contacting UB Securities at email@example.com or telephone +358 (0)9 253 80220.
Where an investor has cancelled their subscription, any subscription price already paid by that investor will be returned to the bank account of the investor given by the investor in connection with the subscription. The funds will be repaid within three local banking days of the cancellation of the subscription. No interest will be paid on the amounts returned.
For further information please visit www.nexstim.com or contact:
| Nexstim |
Janne Huhtala, Chief Executive Officer
| +358 40 8615046 |
| UB Capital Ltd ||+358 (9) 2538 0225|
| Consilium Strategic Communications |
| +44 (0)20 3709 5700 |
This announcement is not a prospectus. The information contained herein does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities referred to herein, in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any jurisdiction. The Offering is made solely on the basis of the prospectus approved by the Finnish Financial Supervisory Authority on 10 October 2014 and passported by way of notification to the Swedish Financial Supervisory Authority.
This communication is not addressed to the public in any Member State of the European Economic Area other than Finland and Sweden. With respect to each Member State of the European Economic Area other than Finland and Sweden (each, a "Relevant Member State"), no action has been undertaken to date to make an offer to the public of the securities requiring a publication of a prospectus in any Relevant Member State. As a result, this communication is only addressed to and directed at qualified investor in the Relevant Member States in circumstances not requiring the Company to publish a prospectus for the purposes of Directive 2003/71/EC (together with any applicable implementing measures in any Member State).
This announcement is not an offer for sale nor a solicitation of an offer to buy any securities in the United States or outside the European Economic Area. The securities referred to in this announcement may not be offered or sold in or into the United States of America absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended. Nexstim has not registered and will not register any part of its contemplated offering in the United States nor will it offer any securities to the public in the United States.
This communication is only being distributed to and is directed only at (i) persons who are outside the United Kingdom, or (ii) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") and (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2) of the Order, and (iv) other persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as "relevant persons"). Any investment or investment activity to which this communication relates will only be available to and will only be engaged in with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents.
Securities in the Company have not been, and will not be, registered under the applicable securities laws of Australia, Canada, Hong Kong, Japan or South Africa and may not be offered or sold within Australia, Canada, Japan or South Africa or to, or for the account or benefit of, citizens or residents of Australia, Canada, Hong Kong, Japan or South Africa except under circumstances which will result in full compliance with the applicable laws and regulations promulgated by the relevant regulatory authorities in effect at the relevant time.
This announcement contains forward looking statements. These forward looking statements include statements that are not historical facts and statements concerning inter alia Nexstim's future revenues, financial position, financial standing, prospects, growth, strategies and its plans, beliefs and current expectations in relation to its field of business. By their very nature, forward looking statements involve inherent risks and uncertainties, since they relate to events or result from circumstances that may or may not occur in the future, and therefore they only describe the circumstances prevailing when the statement is given. Nexstim cautions that forward looking statements or historical facts do not guarantee future performance and that its true revenues, financial position and financial standing and the development of the industry may significantly differ from the forward looking statements presented in this release. The Company does not intend and does not assume any obligation to update any forward looking statement contained herein.
ATTACHMENT: Supplement to Nexstim Plc's Prospectus of 10 October 2014
Nexstim Plc Prospectus supplement with Swedish summary